ArticleJournal of neurointerventional surgery2021
Safety of the APOLLO Onyx delivery microcatheter for embolization of brain arteriovenous malformations: results from a prospective post-market study.
Article in Journal of neurointerventional surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 12 citations in OpenAlex.
- Removal of microcatheter entrapped in the middle cerebral artery in a neonate via common carotid arteriotomy.Journal of vascular surgery cases and innovative techniques · 2025Article
- Multicenter evaluation of preoperative and standalone embolization in meningiomas.Frontiers in oncology · 2025Article
- Modified pressure cooker vs. push-and-plug technique in transarterial embolization for brain arteriovenous malformations: a retrospective comparative study.Frontiers in neurology · 2025Article
- New embolization technique for intracranial vascular disease with the assistance of an Apollo microcatheter.Radiology case reports · 2025Article
- Strategies and outcomes of endovascular treatment of posterior inferior cerebellar artery aneurysms: a single center experience.Neurosurgical review · 2024Article
- Chronological Changes in Embolization for Cerebral Arteriovenous Malformations: Impact of Endovascular Treatment Device Advancements.Journal of neuroendovascular therapy · 2024Article
- Initial experience with the Scepter Mini catheter for the embolization of vascular malformations in the pediatric population.The neuroradiology journal · 2022Article
- How much safety is actually 'safe'? Commentary on 'Safety of the Apollo Onyx delivery microcatheter for embolization of brain arteriovenous malformations: results from a prospective post-market study' by MeyersJournal of neurointerventional surgery · 2021Article
Corrections and comments
- Commented on by
Authors and funding
27 authors at 20 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCatheter retention and difficulty in retrieval have been observed during embolization of brain arteriovenous malformations (bAVMs) with the Onyx liquid embolic system (Onyx). The Apollo Onyx delivery microcatheter (Apollo) is a single lumen catheter designed for controlled delivery of Onyx into the neurovasculature, with a detachable distal tip to aid catheter retrieval. This study evaluates the safety of the Apollo for delivery of Onyx during embolization of bAVMs.
methodsThis was a prospective, non-randomized, single-arm, multicenter, post-market study of patients with a bAVM who underwent Onyx embolization with the Apollo between May 2015 and February 2018. The primary endpoint was any catheter-related adverse event (AE) at 30 days, such as unintentional tip detachment or malfunction with clinical sequelae, or retained catheter. Procedure-related AEs (untoward medical occurrence, disease, injury, or clinical signs) and serious AEs (life threatening illness or injury, permanent physiological impairment, hospitalization, or requiring intervention) were also recorded.
resultsA total of 112 patients were enrolled (mean age 44.1±17.6 years, 56.3% men), and 201 Apollo devices were used in 142 embolization procedures. The mean Spetzler-Martin grade was 2.38. The primary endpoint was not observed (0/112, 0%). The catheter tip detached during 83 (58.5%) procedures, of which 2 (2.4%) were unintentional and did not result in clinical sequelae. At 30 days, procedure related AEs occurred in 26 (23.2%) patients, and procedure-related serious AEs in 12 (10.7%). At 12 months, there were 3 (2.7%) mortalities, including 2 (1.8%) neurological deaths, none of which were device-related.
conclusionThis study demonstrates the safety of Apollo for Onyx embolization of bAVMs. CLINICAL
trial registrationCNCT02378883.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.